Furthermore, excess fructose activates ChREBP and SREBP-1c [28], and high fructose intake may contribute to an increased prevalence of non-alcoholic steatohepatitis (NASH), hepatic fibrosis, and hepatocyte apoptosis [29]. The gene discussed is MLXIPL; the disease is metabolic dysfunction-associated steatohepatitis.